Introduction
Despite advances in diagnosis and treatment of pulmonary embolism (PE), it is still one of the most important causes of mortality and morbidity in all over the world. Determination of risk stage of the PE is not always easy since its clinical signs rapidly change from asymptomatic disease to death (1) . In patients with the suspicion of PE, first of all risk stratification should be performed. Especially among hemodynamically stable patients, in determination of high risk group, echocardiographic findings and cardiac markers are commonly used (2, 3, 4) . However, it is not always easy to attain these procedures. In patients with PE, inexpensive, available and practical tools are necessary to determine prognosis and treatment strategies. Due to this, some investigators focused on about the roles of thrombocytes in thrombus formation (5) . Thrombocytes play a central role in pathogenesis of vascular diseases. The width of thrombocytes are described as mean thrombocyte volume (MPV) and measured with automatic cellular counters routinely. Mean thrombocyte volume is a physiological variable with hemostatic significance. Large thrombocytes are known as more reactive, they produce more prothrombotic factors and they form clusters more easily than smaller ones. Moreover large thrombocytes contain dense granules and secrete serotonin and β-trombo-globulin in larger amounts compared with smaller ones. An association between increased platelet volumes and acute myocardial infarction, acute cerebral ischemia and transient ischemic attack has been reported (5, 6) . Furthermore, an increase in mean platelet volume has been determined as an independent risk factor for recurrent vascular events and death after myocardial infarction. Also, increase in thrombocyte volumes has been reported in patients with renal artery stenosis and patients with vascular risk factors such as diabetes, hypercholesterolemia, and smoking (7, 8) . Kostrubiec et al. (9) reported that MPV is an independent predictor of early death in acute PE. They concluded that high volumes of trombocytes are associated with right ventricular dysfunction and myocardial injury in acute PE. However none of the previous study is investigated the predictive value of MPV in diagnosing the severity of PE. With this background in mind, we aimed to determine the effects of increased thrombocyte functions in development of thrombosis with severity of PE and to investigate the association of thrombocyte volume with PE.
Materials and methods
Three-hundred-twenty-five patients who were hospitalized with the diagnosis of PE in Pulmonary Disease Department between January 2009 -December 2013 and 155 control cases were retrospectively evaluated. Control cases were selected among the patients without any risk factors for vascular disease and who admitted to our hospital for routine control in the same time period. Patients with the history of severe heart failure, myocardial infarction, atherosclerotic heart disease, peripheral artery disease, and chronic obstructive pulmonary disease (COPD), patients with the signs of any infection and patients who had hematological disease which affected platelets were excluded from the study. Patients using any drug (including aspirin, dipiradamol, clopidogrel, heparin, aminophylline, verapamil, nonsteroidantiinflammatory drugs, steroid, furosemide, antibiotics, and alcohol intake) that may affect thrombocyte functions were also excluded. Diagnosis of PE was established with computed tomography angiography. Severity of PE was classified in three groups according to The European Society of Cardiology (ESC) guidelines: High-risk (patients with shock or hypotension), intermediate-risk
[(presence of positive marker for myocardial injury or right ventricle dysfunction (RVD)], lowrisk (absence of RVD or negative marker of myocardial injury) (10) . Results of peripheral complete blood count (hemoglobin, thrombocyte count, white blood cell count, MPV), troponin and pro-BNP values of the venous blood samples, obtained from all cases in the first 24 hours of hospital admission and stored in EDTA tubes, were recorded. The blood samples were studied with the Sysmex-XE 2100 automated blood cell analyzer (Sysmex, Sweden). The expected normal values for MPV in our hematology laboratory ranged from 7.2 to 11.1 fl. Statistical analysis: The software package SPSS for Windows version 17.0 (SPSS Inc., Chicago, III., USA) was used for statistical analyses. The Kolmogorov-Smirnov test was applied to determine the probability distribution. Data were reported as proportions or as mean ±SD. Kruskal Wallis test was used for comparing the groups. The chi-square test was used for comparisons of discrete variables. A P-value<0.05 indicates statistical significance in all analyses. The following variables were considered in the multivariable analysis: demographic features (age, sex), comorbidity (cancer), laboratory findings (serum troponin level), right ventricle dysfunction (RVD) on echocardiography, and computerized tomography (CT) scan findings.
Results
The demographic features and clinical characteristics of study participants are summarized in Table 1 . The mean age of the participants was 68 (range: 21-93) years. The distribution of age was different Table 3 ).
Discussion
The salient finding of the present is higher in subjects with newly diagnosed PE patients and also MPV is strongly associated with the severity of PE. Thrombocytes play a major role in the pathogenesis of athero-trombus formation. The alterations in the volume parameters of thrombocytes may be important in both prophylaxis and diagnosis of thrombotic and pre-thrombotic events (5) . In this study we have determined a significant increase in MPV levels among PE patients compared with the control cases. We showed that MPV may be used as a marker for prediction of severity of acute PE. Thrombocyte volume is a parameter determining thrombocyte function. Larger thrombocytes are more active in terms of hemostatic functions. Alterations in thrombocyte diameters and activities may influence the thrombus formation and development of acute myocardial infarct (11) . In patients with acute myocardial infarct that have increased mean platelet volumes at admission, mortality and revascularization requirement was reported to be higher and it has been also been stated that follow up and treatment of these cases require more care (12, 13) . Platelet activation has been observed after acute PE. Whether platelet activation is a cause or consequence of acute PE in humans is unknown. However, platelet activation correlates with the severity of RV dysfunction, and can persist for several months after acute PE (14) .
In an other study, mean MPV levels were determined to be similar in PE and control cases. However, MPV has been reported to be correlated with parameters of RV dysfunction and myocardial damage reflecting the severity of PE (9) . On the other hand, in similar with this study, Ermis et al. (15) reported that MPV was not an indicator in diagnosis or determination of severity of acute PE however, they also reported that MPV was higher among acute PE. In contrast in our study, similar to the results of Varol et al. (16) , the MPV was reported to be increased among acute PE patients, as compared to controls. Moreover, MPV was higher in massive PE patients compared to the patients with sub-massive or non-massive PE. Günay et al. (17) found that MPV levels were correlated with the pulmonary arterial occlusion level assessed by Computed tomography pulmonary arterial obstruction index ratio (CTPAOIR). These findings suggest that pulmonary arterial occlusion level that was the indicator of the massive PE can be predicted with the increased levels of MPV. Similarly, in our study, MPV levels were determined to be significantly higher in massive PE patients compared to patients with sub-massive or non-massive PE. Vagdatlı et al. (18) showed that MPV was increased during platelet activation. In that study, MPV levels were correlated with troponin. Similarly we also have determined a significant positive correlation between elevated troponin-I levels and increased MPV levels. However, we did not find any correlation between MPV levels and RV dysfunction.
In hemodynamically stable patients, RV dysfunction as observed by echocardiography has been shown to be able to identify patients with poor outcomes who might require more aggressive treatment. The availability of biomarkers like Troponin-I, BNP or NT-pro BNP which are able to identify patients with RV dysfunction early and to contribute these biomarkers to risk stratification is potentially important, especially when echocardiography assessment is not available (19, 20) . Similarly we also have determined a significant positive correlation between elevated troponin-I levels and increased MPV levels. Regarding this correlation, among patients with higher MPV levels, clinicians should be alert about the worse prognosis. In this study, higher MPV levels have been determined in massive and sub-massive PE patients compared with the non-massive PE patients. These results also support our hypothesis that MPV can predict disease severity in acute PE patients. The limitations of the study have to be mentioned. First, this is a cross-sectional study and the potential causal relationship between PE and high MPV levels cannot be concluded. Second, we did not investigate the effect of anticoagulant treatment on MPV levels. Third, we did not follow the patients prospectively and did not compare the survivors and nonsurvivors MPV levels. Fifth, the distribution of age was different in our PE and control cases. However, this study was designed to show the association of MPV levels and severity of acute PE. In conclusion; MPV as a potential marker of platelet activation may correlate with the extent of PE. However it seems not to be a significant predictor of mortality in acute PE. It is supposed that, in risk stratification of patients with acute PE, inserting MPV to the left ventricle dysfunction and increased bio-indicator combination may be helpful in deciding about the thrombolytic treatment. To better clarify that issue, further prospective studies with larger numbers are warranted.
